Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
14.7M
-
Number of holders
-
164
-
Total shares
-
12.4M
-
Shares change
-
-41.1K
-
Total reported value, excl. options
-
$669M
-
Value change
-
-$3.46M
-
Put/Call ratio
-
0
-
Number of buys
-
76
-
Number of sells
-
-68
-
Price
-
$53.91
Significant Holders of Anika Therapeutics, Inc. - Common Stock (ANIK) as of Q4 2017
165 filings reported holding ANIK - Anika Therapeutics, Inc. - Common Stock as of Q4 2017.
Anika Therapeutics, Inc. - Common Stock (ANIK) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.4M shares
of 14.7M outstanding shares and own 84.4% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.88M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1.67M shares), WELLINGTON MANAGEMENT GROUP LLP (1.21M shares), DIMENSIONAL FUND ADVISORS LP (901K shares), Vanguard Group Inc (835K shares), Bank of New York Mellon Corp (527K shares), STATE STREET CORP (379K shares), AMI ASSET MANAGEMENT CORP (276K shares), BTIM Corp. (250K shares), and THOMSON HORSTMANN & BRYANT INC (243K shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.